ArticleRevista brasileira de ortopedia2025
[Updates on Bone Grafts and Substitutes].
Article in Revista brasileira de ortopedia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone defects caused by trauma infections neoplasms and other conditions are commonly treated with autologous grafts which are considered the gold standard due to their osteoinduction osteoconduction and osteogenesis properties. However their use has limitations including limited availability donor-site morbidity and increased surgical time. Alternatively allogeneic grafts xenografts and synthetic bone substitutes including ceramics bioglasses resins and metals have been developed and are often modified with osteoinductive elements such as growth factors and bioinorganic ions. The ideal bone replacement should be biocompatible bioabsorbable mechanically resistant porous and capable of promoting osseointegration. Although synthetic substitutes have advanced they have not yet achieved the effectiveness of autologous grafts especially concerning osteointegration and economic viability. However innovations in molecular biology bone proteins and gene therapies offer promising prospects for the development of new biomaterials. The current article introduces the reader to bone substitutes by presenting a classification of the materials used and the main characteristics of each group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.